Zatula D G, Zaval'niuk A K
Eksp Onkol. 1986;8(6):3-9.
Results of application of the preparations made of mycobacteria, clostridia, staphylococci and streptococci, lactobacteria, Salmonella, Streptomyces and other are analyzed. Researchers in different countries pay great attention to the antitumour activity of capsular and somatic antigens of a microbic cell, its separate anatomical structures, enzymes, lipids, polypeptides and especially polysaccharides. The action of bacterial preparations and factors restraining their application in clinical oncology are considered.
分析了由分枝杆菌、梭菌、葡萄球菌、链球菌、乳酸菌、沙门氏菌、链霉菌等制成的制剂的应用结果。不同国家的研究人员高度关注微生物细胞的荚膜和菌体抗原、其单独的解剖结构、酶、脂质、多肽尤其是多糖的抗肿瘤活性。还考虑了细菌制剂的作用以及限制其在临床肿瘤学中应用的因素。